Research Article
Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism
Figure 1
(a) Variations in body weight levels. (b) Variations in blood glucose levels. Variations in (c) BUN, (d) Scr, (e) urinary protein (24-hour urine), and (f) protein/Scr levels at the end of the experiment ( vs. the Sham group; ## vs. the DKD group, ). (g) Hematoxylin and Eosin staining to observe kidney injury in rats (black arrow: dilation of kidney tubules; green arrow: mesangial matrix hyperplasia; red arrow: eosinophils; purple arrow: glomerular hypertrophy). (h) Masson staining to observe kidney fibrosis in rats. (i) Periodic Acid-Silver-Methenamine staining to observe collagen deposition in rats. (j) Masson staining. (k) Statistical analysis results. The statistical results were compared with the Sham operation group and other groups.
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |
| (g) |
| (j) |
| (k) |